$7.15
0.010.14%
At Close: -
$7.00
-0.15-2.10%
After Hours: Jul 3, 1:01 PM EDT
15 minutes delayed
Oncternal Therapeutics
ONCTNASDAQ
Latest news for Oncternal Therapeutics (NASDAQ:ONCT) Stock
Oncternal Therapeutics Stock (NASDAQ: ONCT)
Categories: All
Friday, May 31, 2024
Thursday, May 30, 2024
Monday, May 13, 2024
Thursday, May 09, 2024
Thursday, April 18, 2024
Monday, April 15, 2024
Tuesday, April 02, 2024
Thursday, March 07, 2024
Wednesday, March 06, 2024
Monday, January 29, 2024
Monday, January 22, 2024
Monday, January 08, 2024
Friday, January 05, 2024
Thursday, January 04, 2024
Wednesday, December 27, 2023
Tuesday, December 26, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Crude Oil Rises Over 3%; US Home Prices Increase In October
- Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level
- Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
- Oncternal Therapeutics Updates The Status Of Its Phase 1/2 Study Of ONCT-808, A ROR1-Targeting Autologous CAR T, In Patients With Relapsed Or Refractory Aggressive B-cell Lymphoma
Friday, December 22, 2023
Thursday, December 21, 2023
Friday, December 08, 2023
Thursday, December 07, 2023
Monday, December 04, 2023
Friday, November 10, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
Thursday, October 26, 2023
Friday, October 06, 2023
Thursday, October 05, 2023
- Oncternal Therapeutics Announces First Patien...
- Chief Technical Officer at Oncternal Therapeutics Exercises Options Worth $204K
- Chief Executive Officer at Oncternal Therapeutics Exercises Options Worth $746K
- Chief Medical Officer at Oncternal Therapeutics Acquires Company Stock Options Worth 782,075 Shares
- Oncternal Therapeutics Chief Financial Officer Awarded $211K Worth of Stock Options